$GEVA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in SYNAGEVA BIOPHARMA CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in SYNAGEVA BIOPHARMA CORP. Get notifications about new insider transactions in SYNAGEVA BIOPHARMA CORP for free.
Page: < prev 1 ... 3 4 5 6 7 8 9 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | D | 48.38 | 740 | 35,801 | 0 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | A | 39.71 | 250 | 9,928 | 250 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | D | 40.85 | 250 | 10,213 | 0 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | A | 41.68 | 250 | 10,420 | 250 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | D | 42.82 | 250 | 10,705 | 0 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | A | 44.09 | 250 | 11,023 | 250 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | D | 45.23 | 250 | 11,308 | 0 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | A | 41.16 | 250 | 10,290 | 250 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | D | 42.30 | 250 | 10,575 | 0 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | A | 46.38 | 1,000 | 46,380 | 1,000 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | D | 47.52 | 1,000 | 47,520 | 0 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Option Exercise | A | 5.90 | 3,322 | 19,600 | 3,322 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Option Exercise | D | 7.04 | 3,322 | 23,387 | 0 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Option Exercise | A | 5.85 | 3,322 | 19,434 | 3,322 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Option Exercise | D | 6.99 | 3,322 | 23,221 | 0 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Option Exercise | A | 6.55 | 3,322 | 21,759 | 3,322 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Option Exercise | D | 7.69 | 3,322 | 25,546 | 0 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Option Exercise | A | 5.91 | 3,322 | 19,633 | 3,322 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Option Exercise | D | 7.05 | 3,322 | 23,420 | 0 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Option Exercise | A | 5.72 | 2,813 | 16,090 | 2,813 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Option Exercise | D | 6.86 | 2,813 | 19,297 | 0 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Option Exercise | A | 11.40 | 2,813 | 32,068 | 2,813 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Option Exercise | D | 12.54 | 2,813 | 35,275 | 0 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Option Exercise | A | 7.44 | 2,813 | 20,929 | 2,813 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Option Exercise | D | 8.58 | 2,813 | 24,136 | 0 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Option Exercise | A | 7.65 | 2,813 | 21,519 | 2,813 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Option Exercise | D | 8.79 | 2,813 | 24,726 | 0 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Option Exercise | A | 11.66 | 1,696 | 19,775 | 1,696 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Option Exercise | D | 12.80 | 1,696 | 21,709 | 0 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Option Exercise | A | 10.65 | 1,696 | 18,062 | 1,696 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Option Exercise | D | 11.79 | 1,696 | 19,996 | 0 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Option Exercise | A | 14.51 | 1,696 | 24,609 | 1,696 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Option Exercise | D | 15.65 | 1,696 | 26,542 | 0 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Option Exercise | A | 11.48 | 1,696 | 19,470 | 1,696 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Option Exercise | D | 12.62 | 1,696 | 21,404 | 0 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Option Exercise | A | 10.81 | 5,000 | 54,050 | 5,000 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Option Exercise | D | 11.95 | 5,000 | 59,750 | 0 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Grant | A | 0.00 | 15,000 | 0 | 15,000 | 30 K to 15 K (-50.00 %) |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | MATTINGLY MARTIN A | Chief Executive Off ... | Option Exercise | A | 6.07 | 350,000 | 2,124,500 | 350,000 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | MATTINGLY MARTIN A | Chief Executive Off ... | Option Exercise | D | 7.21 | 350,000 | 2,523,500 | 0 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | TANG KEVIN C | Director | Option Exercise | A | 5.91 | 12,500 | 73,875 | 12,500 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | TANG KEVIN C | Director | Option Exercise | D | 7.05 | 12,500 | 88,125 | 0 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | TANG KEVIN C | Director | Option Exercise | A | 7.65 | 12,500 | 95,625 | 12,500 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | TANG KEVIN C | Director | Option Exercise | D | 8.79 | 12,500 | 109,875 | 0 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | TANG KEVIN C | Director | Option Exercise | A | 11.48 | 12,500 | 143,500 | 12,500 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | TANG KEVIN C | Director | Option Exercise | D | 12.62 | 12,500 | 157,750 | 0 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | TANG KEVIN C | Director | Option Exercise | A | 13.00 | 11,250 | 146,250 | 11,250 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | TANG KEVIN C | Director | Option Exercise | D | 14.14 | 11,250 | 159,075 | 0 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | TANG KEVIN C | Director | Option Exercise | A | 47.24 | 11,250 | 531,450 | 11,250 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | TANG KEVIN C | Director | Option Exercise | D | 48.38 | 11,250 | 544,275 | 0 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | TANG KEVIN C | Director | Option Exercise | A | 41.16 | 11,250 | 463,050 | 11,250 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | TANG KEVIN C | Director | Option Exercise | D | 42.30 | 11,250 | 475,875 | 0 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | TANG KEVIN C | Director | Option Exercise | A | 37.65 | 20,000 | 753,000 | 20,000 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | TANG KEVIN C | Director | Option Exercise | D | 38.79 | 20,000 | 775,800 | 0 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | DAVIS STEPHEN | Director | Option Exercise | A | 5.91 | 15,000 | 88,650 | 15,000 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | DAVIS STEPHEN | Director | Option Exercise | D | 7.05 | 15,000 | 105,750 | 0 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | DAVIS STEPHEN | Director | Option Exercise | A | 5.70 | 20,000 | 114,000 | 20,000 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | DAVIS STEPHEN | Director | Option Exercise | D | 6.84 | 20,000 | 136,800 | 0 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Quart Barry D | Director | Option Exercise | A | 5.91 | 13,750 | 81,263 | 13,750 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Quart Barry D | Director | Option Exercise | D | 7.05 | 13,750 | 96,938 | 0 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Quart Barry D | Director | Option Exercise | A | 5.70 | 20,000 | 114,000 | 20,000 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Quart Barry D | Director | Option Exercise | D | 6.84 | 20,000 | 136,800 | 0 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | HealthCor Management, L.P. | Director | Option Exercise | A | 5.39 | 40,000 | 215,600 | 60,000 | |
| Aug 08 2008 | GEVA | SYNAGEVA BIOPHARMA ... | HealthCor Management, L.P. | Director | Option Exercise | D | 6.53 | 40,000 | 261,200 | 20,000 | |
| Aug 07 2008 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Option Exercise | A | 5.91 | 13,750 | 81,263 | 13,750 | |
| Aug 07 2008 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Option Exercise | D | 7.05 | 13,750 | 96,938 | 0 | |
| Aug 07 2008 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Option Exercise | A | 7.65 | 11,250 | 86,063 | 11,250 | |
| Aug 07 2008 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Option Exercise | D | 8.79 | 11,250 | 98,888 | 0 | |
| Aug 07 2008 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Option Exercise | A | 11.48 | 11,250 | 129,150 | 11,250 | |
| Aug 07 2008 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Option Exercise | D | 12.62 | 11,250 | 141,975 | 0 | |
| Aug 07 2008 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Option Exercise | A | 13.00 | 11,250 | 146,250 | 11,250 | |
| Aug 07 2008 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Option Exercise | D | 14.14 | 11,250 | 159,075 | 0 | |
| Aug 07 2008 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Option Exercise | A | 13.93 | 20,000 | 278,600 | 20,000 | |
| Aug 07 2008 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Option Exercise | D | 15.07 | 20,000 | 301,400 | 0 | |
| Aug 07 2008 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER JULIAN | Director | Option Exercise | A | 5.91 | 13,750 | 81,263 | 13,750 | |
| Aug 07 2008 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER JULIAN | Director | Option Exercise | D | 7.05 | 13,750 | 96,938 | 0 | |
| Aug 07 2008 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER JULIAN | Director | Option Exercise | A | 7.65 | 11,250 | 86,063 | 11,250 | |
| Aug 07 2008 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER JULIAN | Director | Option Exercise | D | 8.79 | 11,250 | 98,888 | 0 | |
| Aug 07 2008 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER JULIAN | Director | Option Exercise | A | 11.48 | 11,250 | 129,150 | 11,250 | |
| Aug 07 2008 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER JULIAN | Director | Option Exercise | D | 12.62 | 11,250 | 141,975 | 0 | |
| Aug 07 2008 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER JULIAN | Director | Option Exercise | A | 13.00 | 11,250 | 146,250 | 11,250 | |
| Aug 07 2008 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER JULIAN | Director | Option Exercise | D | 14.14 | 11,250 | 159,075 | 0 | |
| Aug 07 2008 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER JULIAN | Director | Option Exercise | A | 13.93 | 20,000 | 278,600 | 20,000 | |
| Aug 07 2008 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER JULIAN | Director | Option Exercise | D | 15.07 | 20,000 | 301,400 | 0 | |
| Jun 30 2008 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER JULIAN | Director | Option Exercise | A | 5.03 | 12,500 | 62,875 | 12,500 | |
| Jun 30 2008 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Option Exercise | A | 5.03 | 13,750 | 69,163 | 13,750 | |
| Jun 30 2008 | GEVA | SYNAGEVA BIOPHARMA ... | TANG KEVIN C | Director | Option Exercise | A | 5.03 | 12,500 | 62,875 | 12,500 | |
| Jun 30 2008 | GEVA | SYNAGEVA BIOPHARMA ... | DAVIS STEPHEN | Director | Option Exercise | A | 5.03 | 15,000 | 75,450 | 15,000 | |
| Jun 30 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Quart Barry D | Director | Option Exercise | A | 5.03 | 13,750 | 69,163 | 13,750 | |
| Jun 30 2008 | GEVA | SYNAGEVA BIOPHARMA ... | MATTINGLY MARTIN A | Chief Executive Off ... | Option Exercise | A | 5.03 | 89,088 | 448,113 | 89,088 | |
| Jun 30 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Option Exercise | A | 5.03 | 44,544 | 224,056 | 44,544 | |
| Jun 30 2008 | GEVA | SYNAGEVA BIOPHARMA ... | HealthCor Management, L.P. | Director | Option Exercise | A | 5.03 | 2 | 10 | 60,000 | |
| Jun 30 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | A | 5.03 | 44,544 | 224,056 | 44,544 | |
| Apr 01 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Chief Financial Off ... | Option Exercise | A | 7.04 | 3,322 | 23,387 | 3,322 | |
| Apr 01 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Alrutz Michael A | General Counsel | Option Exercise | A | 7.04 | 3,322 | 23,387 | 3,322 | |
| Apr 01 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Ohmstede Carol | Option Exercise | A | 7.04 | 5,533 | 38,952 | 5,533 | ||
| Feb 12 2008 | GEVA | SYNAGEVA BIOPHARMA ... | HealthCor Management, L.P. | 10% Owner | Option Exercise | A | 6.53 | 40,000 | 261,200 | 40,000 | |
| Mar 19 2008 | GEVA | SYNAGEVA BIOPHARMA ... | HealthCor Management, L.P. | Director | Buy | P | 6.22 | 463,657 | 2,883,947 | 4,413,657 | 4 M to 4.4 M (+11.74 %) |
| Jan 02 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Director of Finance | Option Exercise | A | 6.99 | 3,322 | 23,221 | 3,322 | |
| Jan 02 2008 | GEVA | SYNAGEVA BIOPHARMA ... | Ohmstede Carol | Option Exercise | A | 6.99 | 5,533 | 38,676 | 5,533 | ||
| Nov 16 2007 | GEVA | SYNAGEVA BIOPHARMA ... | MATTINGLY MARTIN A | Chief Executive Off ... | Option Exercise | A | 7.21 | 350,000 | 2,523,500 | 350,000 | |
| Oct 03 2007 | GEVA | SYNAGEVA BIOPHARMA ... | HealthCor Management, L.P. | 10% Owner | Buy | P | 7.78 | 54,410 | 423,255 | 3,950,000 | 3.9 M to 4 M (+1.40 %) |
| Oct 02 2007 | GEVA | SYNAGEVA BIOPHARMA ... | Ohmstede Carol | Option Exercise | A | 7.69 | 5,533 | 42,549 | 5,533 | ||
| Oct 02 2007 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Director of Finance | Option Exercise | A | 7.69 | 3,322 | 25,546 | 3,322 | |
| Oct 01 2007 | GEVA | SYNAGEVA BIOPHARMA ... | HealthCor Management, L.P. | 10% Owner | Buy | P | 7.64 | 145,590 | 1,112,453 | 3,895,590 | 3.8 M to 3.9 M (+3.88 %) |
| Oct 01 2007 | GEVA | SYNAGEVA BIOPHARMA ... | HealthCor Management, L.P. | 10% Owner | Buy | P | 7.39 | 33,746 | 249,518 | 3,750,000 | 3.7 M to 3.8 M (+0.91 %) |
| Sep 25 2007 | GEVA | SYNAGEVA BIOPHARMA ... | HealthCor Management, L.P. | 10% Owner | Buy | P | 7.11 | 300,000 | 2,133,600 | 3,716,254 | 3.4 M to 3.7 M (+8.78 %) |
| Sep 11 2007 | GEVA | SYNAGEVA BIOPHARMA ... | HealthCor Management, L.P. | 10% Owner | Buy | P | 7.11 | 10,829 | 76,994 | 3,416,254 | 3.4 M to 3.4 M (+0.32 %) |
| Sep 11 2007 | GEVA | SYNAGEVA BIOPHARMA ... | HealthCor Management, L.P. | 10% Owner | Buy | P | 7.07 | 54,525 | 385,655 | 3,405,425 | 3.4 M to 3.4 M (+1.63 %) |
| Sep 11 2007 | GEVA | SYNAGEVA BIOPHARMA ... | HealthCor Management, L.P. | 10% Owner | Buy | P | 7.01 | 1,300 | 9,110 | 3,350,900 | 3.3 M to 3.4 M (+0.04 %) |
| Sep 11 2007 | GEVA | SYNAGEVA BIOPHARMA ... | HealthCor Management, L.P. | 10% Owner | Buy | P | 7.01 | 9,600 | 67,325 | 3,349,600 | 3.3 M to 3.3 M (+0.29 %) |
| Aug 23 2007 | GEVA | SYNAGEVA BIOPHARMA ... | BRIDGER MANAGEMENT LLC | 10% Owner | Buy | P | 7.00 | 10,081 | 70,567 | 2,510,081 | 2.5 M to 2.5 M (+0.40 %) |
| Aug 22 2007 | GEVA | SYNAGEVA BIOPHARMA ... | BRIDGER MANAGEMENT LLC | 10% Owner | Buy | P | 7.07 | 31,893 | 225,484 | 2,500,000 | 2.5 M to 2.5 M (+1.29 %) |
| Aug 17 2007 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Director of Finance | Option Exercise | A | 7.05 | 3,322 | 23,420 | 3,322 | |
| Aug 16 2007 | GEVA | SYNAGEVA BIOPHARMA ... | DAVIS STEPHEN | Director | Option Exercise | A | 7.05 | 15,000 | 105,750 | 15,000 | |
| Aug 16 2007 | GEVA | SYNAGEVA BIOPHARMA ... | TANG KEVIN C | Director | Option Exercise | A | 7.05 | 12,500 | 88,125 | 12,500 | |
| Aug 17 2007 | GEVA | SYNAGEVA BIOPHARMA ... | Ohmstede Carol | Option Exercise | A | 7.05 | 5,533 | 39,008 | 5,533 | ||
| Aug 16 2007 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER JULIAN | Director | Option Exercise | A | 7.05 | 12,500 | 88,125 | 12,500 | |
| Aug 16 2007 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Option Exercise | A | 7.05 | 13,750 | 96,938 | 13,750 | |
| Jul 17 2007 | GEVA | SYNAGEVA BIOPHARMA ... | BOLOGNESI DANI P | Director | Option Exercise | A | 0.00 | 50,000 | 0 | 50,000 | |
| Aug 16 2007 | GEVA | SYNAGEVA BIOPHARMA ... | Quart Barry D | Director | Option Exercise | A | 7.05 | 13,750 | 96,938 | 13,750 | |
| Aug 14 2007 | GEVA | SYNAGEVA BIOPHARMA ... | HealthCor Management, L.P. | 10% Owner | Buy | P | 6.95 | 184,905 | 1,285,460 | 3,339,190 | 3.2 M to 3.3 M (+5.86 %) |
| Jun 29 2007 | GEVA | SYNAGEVA BIOPHARMA ... | DAVIS STEPHEN | Director | Option Exercise | A | 6.84 | 20,000 | 136,800 | 20,000 | |
| May 17 2007 | GEVA | SYNAGEVA BIOPHARMA ... | Ohmstede Carol | Sell | S | 7.14 | 5,616 | 40,098 | 0 | 5.6 K to 0 (-100.00 %) | |
| Jun 29 2007 | GEVA | SYNAGEVA BIOPHARMA ... | Quart Barry D | Director | Option Exercise | A | 6.84 | 20,000 | 136,800 | 20,000 | |
| Apr 02 2007 | GEVA | SYNAGEVA BIOPHARMA ... | BONCZEK ROBERT R | CFO and General Cou ... | Option Exercise | A | 6.86 | 9,375 | 64,313 | 9,375 | |
| Apr 02 2007 | GEVA | SYNAGEVA BIOPHARMA ... | BONCZEK ROBERT R | CFO and General Cou ... | Option Exercise | A | 6.86 | 9,375 | 64,313 | 9,375 | |
| Apr 02 2007 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Director of Finance | Option Exercise | A | 6.86 | 2,813 | 19,297 | 2,813 | |
| Mar 01 2007 | GEVA | SYNAGEVA BIOPHARMA ... | BONCZEK ROBERT R | CFO and General Cou ... | Option Exercise | M | 0.34 | 3,530 | 1,200 | 3,530 | |
| Mar 01 2007 | GEVA | SYNAGEVA BIOPHARMA ... | BONCZEK ROBERT R | CFO and General Cou ... | Buy | M | 0.34 | 3,530 | 1,200 | 28,884 | 25.4 K to 28.9 K (+13.92 %) |
| Feb 02 2007 | GEVA | SYNAGEVA BIOPHARMA ... | Baker Bros. Capital (GP), LLC | Director | Sell | J | 0.00 | 14,779 | 0 | 316,360 | 331.1 K to 316.4 K (-4.46 %) |
| Jan 04 2007 | GEVA | SYNAGEVA BIOPHARMA ... | BOLOGNESI DANI P | Chief Executive Off ... | Option Exercise | A | 12.54 | 9,375 | 117,563 | 9,375 | |
| Jan 04 2007 | GEVA | SYNAGEVA BIOPHARMA ... | BONCZEK ROBERT R | CFO and General Cou ... | Option Exercise | A | 12.54 | 9,375 | 117,563 | 9,375 | |
| Jan 04 2007 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Director of Finance | Option Exercise | A | 12.54 | 2,813 | 35,275 | 2,813 | |
| Oct 04 2006 | GEVA | SYNAGEVA BIOPHARMA ... | Baker / Tisch Capital (GP), LL ... | Director | Sell | J | 0.00 | 126,415 | 0 | 160,420 | 286.8 K to 160.4 K (-44.07 %) |
| Oct 02 2006 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Director of Finance | Option Exercise | A | 8.58 | 2,813 | 24,136 | 2,813 | |
| Oct 02 2006 | GEVA | SYNAGEVA BIOPHARMA ... | BOLOGNESI DANI P | Chief Scientific Of ... | Option Exercise | A | 8.58 | 9,375 | 80,438 | 9,375 | |
| Oct 02 2006 | GEVA | SYNAGEVA BIOPHARMA ... | BONCZEK ROBERT R | CFO and General Cou ... | Option Exercise | A | 8.58 | 9,375 | 80,438 | 9,375 | |
| Oct 02 2006 | GEVA | SYNAGEVA BIOPHARMA ... | Skolsky Steven D | Chief Executive Off ... | Option Exercise | A | 8.58 | 18,750 | 160,875 | 18,750 | |
| Aug 11 2006 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER JULIAN | Director | Option Exercise | A | 8.79 | 11,250 | 98,888 | 11,250 | |
| Aug 11 2006 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Option Exercise | A | 8.79 | 11,250 | 98,888 | 11,250 | |
| Aug 10 2006 | GEVA | SYNAGEVA BIOPHARMA ... | CROUT J RICHARD | Director | Option Exercise | A | 8.79 | 12,500 | 109,875 | 12,500 | |
| Aug 10 2006 | GEVA | SYNAGEVA BIOPHARMA ... | TANG KEVIN C | Director | Option Exercise | A | 8.79 | 12,500 | 109,875 | 12,500 | |
| Aug 10 2006 | GEVA | SYNAGEVA BIOPHARMA ... | COOK GARY | Director | Option Exercise | A | 8.79 | 15,000 | 131,850 | 15,000 | |
| Aug 10 2006 | GEVA | SYNAGEVA BIOPHARMA ... | LIPTON JEFFREY M | Director | Option Exercise | A | 8.79 | 20,000 | 175,800 | 20,000 | |
| Aug 09 2006 | GEVA | SYNAGEVA BIOPHARMA ... | Graham Andrew L | Director of Finance | Option Exercise | A | 8.79 | 2,813 | 24,726 | 2,813 | |
| Aug 09 2006 | GEVA | SYNAGEVA BIOPHARMA ... | BOLOGNESI DANI P | Chief Scientific Of ... | Option Exercise | A | 8.79 | 9,375 | 82,406 | 9,375 | |
| Aug 09 2006 | GEVA | SYNAGEVA BIOPHARMA ... | BONCZEK ROBERT R | CFO and General Cou ... | Option Exercise | A | 8.79 | 9,375 | 82,406 | 9,375 | |
| Aug 09 2006 | GEVA | SYNAGEVA BIOPHARMA ... | Skolsky Steven D | Chief Executive Off ... | Option Exercise | A | 8.79 | 18,750 | 164,813 | 18,750 | |
| Apr 28 2006 | GEVA | SYNAGEVA BIOPHARMA ... | Baker Brothers Life Sciences C ... | Director | Buy | J | 0.00 | 1,228,857 | 0 | 1,228,857 | 0 to 1.2 M |